These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7694515)

  • 1. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Abenoza P; Lillemoe T
    Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR; Tuthill RJ
    Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
    Cohen PR; Rapin RP; Farhood AI
    Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
    Zelger BW; Ofner D; Zelger BG
    Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans].
    Xiong Y; Guo H; Zhang S; Zhang B; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):395-400. PubMed ID: 18677387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL; Cardona DM; Su Z; Puri PK
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.
    Hsi ED; Nickoloff BJ
    J Dermatol Sci; 1996 Jan; 11(1):1-9. PubMed ID: 8867761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
    Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
    Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
    Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
    J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
    Kutzner H
    J Am Acad Dermatol; 1993 Apr; 28(4):613-7. PubMed ID: 7681857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Immunohistochemistry Deceives Us: The Pitfalls of CD34 and Factor XIIIa Stains in Dermatofibroma and Dermatofibrosarcoma Protuberans.
    John AM; Holahan HH; Singh P; Handler MZ; Lambert WC
    Skinmed; 2017; 15(1):53-55. PubMed ID: 28270311
    [No Abstract]   [Full Text] [Related]  

  • 18. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E; Augsburger E; Chavaz P; Saurat JH; Kaya G
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
    Bandarchi B; Ma L; Marginean C; Hafezi S; Zubovits J; Rasty G
    Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
    Labonte S; Hanna W; Bandarchi-Chamkhaleh B
    J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.